XML 237 R37.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-based Compensation (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Jun. 30, 2022
Jun. 30, 2021
Restricted Stock Units (RSUs)                
Share-based Payment activity [Roll Forward]                
Unvested at beginning of period (in shares) 786,800 912,400   940,300 1,096,200   912,400 1,096,200
Granted (in shares) 188,500     200,500     188,500 257,100
Vested (in shares) (28,600)     (10,700)     (151,400) (218,100)
Forfeited (in shares) (7,700)     (12,000.0)     (10,500) (17,100)
Unvested at end of period (in shares) 939,000.0 786,800 912,400 1,118,100 940,300 1,096,200 939,000.0 1,118,100
Performance Shares [Member]                
Share-based Payment activity [Roll Forward]                
Unvested at beginning of period (in shares) 466,100 646,000.0   439,100 531,500   646,000.0 531,500
Granted (in shares) 113,000.0     107,200     113,000.0 107,200
Vested (in shares) 0     0     (175,100) (79,000.0)
Forfeited (in shares) (2,200)     (1,100)     (7,000.0) (14,500)
Unvested at end of period (in shares) 576,900 466,100 646,000.0 545,200 439,100 531,500 576,900 545,200
Share-based Payment Arrangement [Member]                
Share-based Payment activity [Roll Forward]                
Unvested at beginning of period (in shares) 1,252,900 1,558,400   1,379,400 1,627,700   1,558,400 1,627,700
Granted (in shares) 301,500     307,700     301,500 364,300
Vested (in shares) (28,600)     (10,700)     (326,500) (297,100)
Forfeited (in shares) (9,900)     (13,100)     (17,500) (31,600)
Unvested at end of period (in shares) 1,515,900 1,252,900 1,558,400 1,663,300 1,379,400 1,627,700 1,515,900 1,663,300
Share-based Payment activity, additional disclosures [Abstract]                
Weighted average grant date fair value, beginning of period (in dollars per share) $ 152.62 $ 152.27   $ 134.84 $ 137.42   $ 152.27 $ 137.42
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value 224.59     186.21     223.61 179.95
Weighted average grant date fair value, vested (in dollars per share) 129.96     142.07     147.57 150.45
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 173.02     123.85     173.44 138.47
Weighted average grant date fair value, end of period (in dollars per share) $ 167.23 $ 152.62 $ 152.27 $ 144.01 $ 134.84 $ 137.42 $ 167.23 $ 144.01
Weighted average remaining contractual life, unvested shares outstanding 1 year 11 months 23 days 1 year 10 months 2 days 1 year 11 months 26 days 1 year 11 months 1 day 1 year 8 months 12 days 1 year 8 months 8 days 1 year 11 months 23 days 1 year 11 months 1 day
Unamortized deferred compensation cost $ 121.8           $ 121.8